LA News Center: Goldman Sachs Unveils Refreshed Stock Picks
In a major shakeup, global investment bank Goldman Sachs has unveiled its updated “Conviction List – Directors’ Cut,” featuring 15 to 25 handpicked stocks with exceptional upside potential. These selections are carefully curated by subcommittees and sector analysts, targeting a combination of strong conviction, differentiated views, and attractive risk-adjusted returns.
Asia-Pacific and Europe’s Bright Stars
Goldman is singing the praises of three companies from Asia-Pacific and Europe that are poised for significant growth in the coming year, each with over 30% potential upside.
-
London Stock Exchange (LSEG):
- Analysts see LSEG’s organic revenue growth exceeding the industry norm, driven by increased wallet share and market expansion.
- Goldman’s target price of 11,850 British pence implies a 30.7% upside potential.
-
Samsung Biologics (South Korea):
- The biotechnology giant is a major player in the growing biologics CDMO market.
- Its competitive pricing strategy and partnerships with leading global players position it for significant growth.
- Goldman sets a target price of 1,078,000 Korean won with a potential upside of nearly 40%.
-
Neste (Finland):
- The oil refining company is well-positioned to capitalize on regulatory tailwinds driving biofuels demand.
- EU and US biofuels mandates will significantly boost its profitability in the coming years.
- Goldman predicts a massive 67% upside potential, with a target price of 37 euros.
